SLC35F2: A Drug Target / Disease Biomarker (G54733)

Target Name: SLC35F2

NCBI ID: G54733

SLC35F2

SLC35F2: A Drug Target / Disease Biomarker

SLC35F2 is a protein that is expressed in the brain and is involved in the regulation of cell signaling pathways. It is a member of the SLC family of transport proteins, which are known for their ability to transport a wide variety of molecules across cell membranes. SLC35F2 has been identified as a potential drug target or biomarker for the treatment of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

SLC35F2 is expressed in the brain and is involved in the regulation of cell signaling pathways.

SLC35F2 is a member of the SLC family of transport proteins, which are known for their ability to transport a wide variety of molecules across cell membranes. These proteins have an average transmembrane potential of about 60 mV and are able to transport substances that are either cationic or anion

Protein Name: Solute Carrier Family 35 Member F2

Functions: Putative solute transporter

The "SLC35F2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC35F2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets